[topsearch__bar__shortcode]

November 15, 2024

Court Ruling Boosts Greenidge (GREE) Stock In Pre-Hour Trading

Greenidge Generation Holdings Inc. (NASDAQ: GREE) shares are on a notable surge on the US stock charts following a favorable court decision. The New York Supreme Court ruled in favor of the company in its ongoing dispute with the New York State Department of Environmental Conservation (DEC). As a result, GREE stock is surging 51.01% […]

Court Ruling Boosts Greenidge (GREE) Stock In Pre-Hour Trading Read More »

Pre-Market Jump For Beneficient (BENF) After Profitable Quarter

Beneficient (NASDAQ: BENF) has experienced a significant pre-market surge in its stock price following the announcement of its fiscal Q2 2024 results, with shares increasing by 51.19% to $1.89 as of the last check. This marks the company’s second consecutive profitable quarter as a public entity, solidifying its position as a leading solution provider for

Pre-Market Jump For Beneficient (BENF) After Profitable Quarter Read More »

AC Immune (ACIU) Sees Stock Boost Following Positive Trial Data

Following the release of positive preliminary findings from its Phase 2 VacSYn clinical study, shares of AC Immune SA (NASDAQ: ACIU) saw a notable increase, jumping 13.42% on the charts. The anti-alpha-synuclein (a-syn) active immunotherapy ACI-7104.056, which targets early-stage Parkinson’s disease (PD), is being evaluated in this experiment. ACIU stock ended Thursday’s trading session at

AC Immune (ACIU) Sees Stock Boost Following Positive Trial Data Read More »

Moleculin (MBRX) Stock Jumps On Accelerated Clinical Trial News

During previous trading session, the stock price of Moleculin Biotech, Inc. (NASDAQ: MBRX) saw a notable uptick, rising 23.11% to close at $3.09. This encouraging development came after MBRX revealed a revised clinical trial design for its Phase 3 pivotal trial, which evaluates the use of Annamycin and Cytarabine to treat relapsed or refractory acute

Moleculin (MBRX) Stock Jumps On Accelerated Clinical Trial News Read More »

AgEagle (UAVS) Stock Skyrockets Following Defense Contract Wins

AgEagle Aerial Systems, Inc. (NYSE: UAVS) shares went through a remarkable surge, soaring 122.36% in the last trading session to conclude at $3.58. This significant uptick in UAVS stock followed the announcement of several new contracts, marking a pivotal achievement for the company. Contracts for Strategic Use Support the Defense Market’s Growth AgEagle’s ambition to

AgEagle (UAVS) Stock Skyrockets Following Defense Contract Wins Read More »

Kaixin (KXIN) Recovers After-Hour Amid Strategic Shift Towards Cryptocurrency

During Thursday’s extended trading session, shares of Kaixin Holdings (NASDAQ: KXIN) recovered significantly, rising 12% to $2.80. This recovery helped to somewhat counteract a steep drop of more than 40% during regular trading hours. The volatility followed the company’s announcement of a significant strategic initiative centered around digital assets. Exploring Cryptocurrency Expansion Kaixin declared its

Kaixin (KXIN) Recovers After-Hour Amid Strategic Shift Towards Cryptocurrency Read More »

After-Market Rally: Evotec (EVO) Surges Following Acquisition Proposal

The shares of Evotec SE (NASDAQ: EVO) continued to rise sharply on Thursday in response to Halozyme Therapeutics’ purchase proposal. After increasing 12.09% during normal trading, EVO’s shares rose 11.57% to $5.69 in after-hours trading. Increased investor confidence is demonstrated by the announcement of Halozyme’s effort to purchase Evotec for €11.00 per share in cash,

After-Market Rally: Evotec (EVO) Surges Following Acquisition Proposal Read More »